The Retrobulbar Spot Sign and Prominent Middle Limiting Membrane as Prognostic Markers in Non-Arteritic Retinal Artery Occlusion.

central retinal artery occlusion imaging optical coherence tomography prognosis sudden vision loss visual acuity

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
18 Jan 2021
Historique:
received: 13 11 2020
revised: 11 12 2020
accepted: 14 01 2021
entrez: 22 1 2021
pubmed: 23 1 2021
medline: 23 1 2021
Statut: epublish

Résumé

Central retinal artery occlusion (CRAO) is characterized by the sudden, painless loss of vision. Typical sonographic and optic coherence tomography (OCT) findings are a retrobulbar spot sign and prominent middle limiting membrane (p-MLM) sign. It remains uncertain whether the retrobulbar spot sign alone or coinciding with the appearance of p-MLM sign is a prognostic marker for visual acuity and the development of secondary retinal ischemia after CRAO. In our prospective cohort study, we included patients with a non-arteritic central artery occlusion < 4 weeks. We examined the following parameters at prespecified time points: ultrasound examination of orbital cavity, Spectral Domain-OCT examination, visual acuity test, and fundoscopy and ultra-widefield angiography to diagnose retinal vascularization. The presence of p-MLM sign in SD-OCT after CRAO was accompanied by significantly better vision during the first four weeks (2.3 (IQR 0.75) vs. 2.6 (IQR 0.33);

Identifiants

pubmed: 33477523
pii: jcm10020338
doi: 10.3390/jcm10020338
pmc: PMC7831102
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Neuroimaging. 2015 Mar-Apr;25(2):251-256
pubmed: 24641564
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1236-40
pubmed: 16505064
Stroke. 2011 Aug;42(8):2229-34
pubmed: 21757667
Semin Ophthalmol. 2017;32(1):125-133
pubmed: 27780399
Eye (Lond). 2010 Apr;24(4):678-81
pubmed: 19521436
Retina. 2013 Nov-Dec;33(10):2110-7
pubmed: 23594722
Lancet Neurol. 2014 Apr;13(4):429-38
pubmed: 24646875
Graefes Arch Clin Exp Ophthalmol. 2009 Jan;247(1):137-42
pubmed: 18766368
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Stroke. 2015 Aug;46(8):2322-4
pubmed: 26111890
PLoS One. 2017 Aug 3;12(8):e0181766
pubmed: 28771491
Ophthalmology. 2015 Sep;122(9):1881-8
pubmed: 26231133
BMC Ophthalmol. 2019 Jul 10;19(1):147
pubmed: 31291918
Eye (Lond). 2020 Apr;34(4):683-689
pubmed: 31527762
Mayo Clin Proc. 2019 Feb;94(2):236-241
pubmed: 30711121
Retina. 2014 Jun;34(6):1132-41
pubmed: 24378425
Ann Eye Sci. 2018 Jun;3:
pubmed: 30198015
J Neuroophthalmol. 2018 Sep;38(3):328-333
pubmed: 29369960
N Engl J Med. 1991 Aug 15;325(7):445-53
pubmed: 1852179
Ophthalmology. 2010 Jul;117(7):1367-75.e1
pubmed: 20609991
J Neuroophthalmol. 2007 Sep;27(3):215-30
pubmed: 17895823
Stroke. 2020 Mar;51(3):800-807
pubmed: 31951154
Ultraschall Med. 2012 Dec;33(7):E263-E267
pubmed: 23023446
Ophthalmology. 2017 Feb;124(2):P120-P143
pubmed: 27742458
Asia Pac J Ophthalmol (Phila). 2018 Jul-Aug;7(4):235-241
pubmed: 29717825
Retina. 2011 Apr;31(4):730-7
pubmed: 21242861
J Ultrasound Med. 2020 Jan;39(1):197-202
pubmed: 31228289
Stroke. 2019 Sep;50(9):e253-e256
pubmed: 31449481
Am J Ophthalmol. 2005 Sep;140(3):376-91
pubmed: 16138997

Auteurs

Marlena Schnieder (M)

Department of Neurology, University Medical Center Göttingen, 37073 Göttingen, Germany.

Charlotte V Fischer-Wedi (CV)

Department of Ophthalmology, University Medical Center Göttingen, 37073 Göttingen, Germany.

Sebastian Bemme (S)

Department of Ophthalmology, University Medical Center Göttingen, 37073 Göttingen, Germany.

Mai-Linh Kortleben (ML)

Department of Ophthalmology, University Medical Center Göttingen, 37073 Göttingen, Germany.

Nicolas Feltgen (N)

Department of Ophthalmology, University Medical Center Göttingen, 37073 Göttingen, Germany.

Jan Liman (J)

Department of Neurology, University Medical Center Göttingen, 37073 Göttingen, Germany.

Classifications MeSH